Provided by Tiger Trade Technology Pte. Ltd.

ADC Therapeutics SA

4.60
+0.36008.49%
Post-market: 4.720.1200+2.61%17:42 EST
Volume:1.30M
Turnover:5.83M
Market Cap:569.83M
PE:-3.19
High:4.62
Open:4.30
Low:4.23
Close:4.24
52wk High:4.80
52wk Low:1.05
Shares:123.88M
Float Shares:92.24M
Volume Ratio:2.41
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4417
EPS(LYR):-1.6246
ROE:-705.53%
ROA:-23.98%
PB:-2.39
PE(LYR):-2.83

Loading ...

Nov 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Oct 14, 2025

Major Issues Report

Form 8-K - Current report
Sep 30, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 30, 2025

Major Issues Report

Form 8-K - Current report
Aug 12, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Jul 08, 2025

Correspondence

Form CORRESP - Correspondence
Jun 12, 2025

Major Issues Report

Form 8-K - Current report
Jun 05, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2025

Major Issues Report

Form 8-K - Current report
Mar 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]